GP1BA and neoplasm: Platelet cell membrane-coated NPs containing GPIbα or genetically overexpressed GPIbα can be employed for targeting platelet-derived cancer and tumor microenvironment responsive drug delivery for hepatocellular carcinoma[120,121].